0QLQ.LSE Ypsomed Holding AG

Healthcare Commercial Services & Supplies London Exchange
279.70 GBP
Close of Nov 3, 2026
263.48 417.00
Market cap
GBP 3.53B
P/E
219.2x
P/B
-
ROE
29.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Mar 2026.

Is 0QLQ.LSE undervalued?

Graham number

The Graham number of Ypsomed Holding AG cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Ypsomed Holding AG fundamental analysis

No fundamental analysis for Ypsomed Holding AG yet.

Ypsomed Holding AG stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Ypsomed Holding AG

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication in Switzerland, Europe, North America, and internationally. The company offers various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other related services. It offers contract manufacturing of infusion sets and reservoirs. The company markets its products to hospitals, doctors, …

Full company profile